Search - tctmd.com

Displaying 81 - 100 of 108

Sort: Relevancy | Date

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Features

Despite New Findings, Optimal DAPT Duration Still Up in the Air

Todd Neale

December 10, 2014

News Daily News

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

September 02, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

News Conference News ACC 2014

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

April 02, 2014

News Daily News

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

L.A. McKeown

March 27, 2014

News Daily News

Ticagrelor Loading Dose May be Unnecessary for ACS Patients Previously on Clopidogrel

Caitlin E. Cox

January 29, 2014

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Daily News

PARADOX Published: Smokers’ Paradox Seen with Clopidogrel But not Prasugrel

Caitlin E. Cox

May 13, 2013

News Daily News

PARADOX Publicado: La Paradoja del Fumador se observa con el Clopidogrel pero No con el Prasugrel

Caitlin E. Cox

May 13, 2013

Presentation

PARADOX: Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel

Presenter: Paul A. Gurbel

May 03, 2013

News Daily News

Unknowns Predominate in Variable Clopidogrel Response

January 16, 2013

News Daily News

Predominan Factores Desconocidos en la Respuesta Variable al Clopidogrel

January 16, 2013

Presentation

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms, Noncompliance, Diet, Smoking, Co-medications, and Preexistent Variability in Platelet Func

Presenter: Andrew L. Frelinger

January 15, 2013

News Daily News

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Caitlin E. Cox

December 16, 2012

Presentation TCT 2012

TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study

Presenter: Paul Gurbel

October 23, 2012

Presentation

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Presenter: Jan H. Cornel

August 02, 2012

News Daily News

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Yael L. Maxwell

June 20, 2012

News Daily News

Señales Apuntan a la Relación que existe entre la Eficacia del Clopidogrel y el Tabaquismo

Yael L. Maxwell

June 20, 2012

News Daily News

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

L.A. McKeown

May 23, 2012

Advertisement

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Despite New Findings, Optimal DAPT Duration Still Up in the Air

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

Ticagrelor Loading Dose May be Unnecessary for ACS Patients Previously on Clopidogrel

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

PARADOX Published: Smokers’ Paradox Seen with Clopidogrel But not Prasugrel

PARADOX Publicado: La Paradoja del Fumador se observa con el Clopidogrel pero No con el Prasugrel

PARADOX: Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel

Unknowns Predominate in Variable Clopidogrel Response

Predominan Factores Desconocidos en la Respuesta Variable al Clopidogrel

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms, Noncompliance, Diet, Smoking, Co-medications, and Preexistent Variability in Platelet Func

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study

Prior Smoking Status, Clinical Outcomes, and the Comparison of Ticagrelor with Clopidogrel in ACS

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Señales Apuntan a la Relación que existe entre la Eficacia del Clopidogrel y el Tabaquismo

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content